Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Parosmia
ADR ID BADD_A03313
ADR Hierarchy
17      Nervous system disorders
17.04      Cranial nerve disorders (excl neoplasms)
17.04.04      Olfactory nerve disorders
17.04.04.002      Parosmia
22      Respiratory, thoracic and mediastinal disorders
22.04      Upper respiratory tract disorders (excl infections)
22.04.03      Nasal disorders NEC
22.04.03.007      Parosmia
Description Loss of or impaired ability to smell. This may be caused by OLFACTORY NERVE DISEASES; PARANASAL SINUS DISEASES; viral RESPIRATORY TRACT INFECTIONS; CRANIOCEREBRAL TRAUMA; SMOKING; and other conditions. | Absence of the sense of smell. (Dorland, 27th ed) [MeSH]
MedDRA Code 10034018
MeSH ID D000857
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Altered smell sensation | Disturbances of sensation of smell and taste | Disturbances of smell and taste | Dysomia | Dysosmia | Dysosmia NOS | Faint odor of sulfur | Hyperosmia | Parosmia | Perversion olfactory | Smell alteration | Smell change | Smell perversion | Smelly sensation | Strange smell sensation | Cacosmia | Faint odour of sulfur | Phantosmia | Olfactism | Heterosmia | Allotriosmia | Metallic smell | Olfaction Disorders | Olfaction Disorder | Smell Disorders | Smell Disorder | Cacosmias | Dysosmias | Paraosmia | Paraosmias | Anosmia
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00984Gadobutrol--
BADD_D00987Gadofosveset--
BADD_D00989Gadolinium--
BADD_D00990Gadolinium-dtpa--
BADD_D00991Gadopentetate dimeglumine--
BADD_D00992Gadoterate meglumine--
BADD_D00994Gadoversetamide--
BADD_D00995Gadoxetate disodium--
BADD_D01006Gatifloxacin--
BADD_D01117Ibandronic acid--
BADD_D01119Ibrutinib0.000358%
BADD_D01166Interferon alfa-2a--
BADD_D01167Interferon alfa-2b--
BADD_D01178Iodixanol--
BADD_D01191Ipratropium--
BADD_D01243Lamotrigine--
BADD_D01245Lansoprazole--
BADD_D01253Lenalidomide0.012321%
BADD_D01260Leuprolide acetate--
BADD_D01274Levodopa-4'-monophosphate--
BADD_D01275Levofloxacin0.000084%
BADD_D01281Levonorgestrel--
BADD_D01285Levothyroxine0.000010%
BADD_D01290Lifitegrast0.001763%
BADD_D01345Magnevist--
BADD_D01397Mesalamine--
BADD_D01401Metformin0.000017%
BADD_D01418Methotrexate--
BADD_D01445Metoprolol0.000013%
BADD_D01449Metronidazole0.000116%
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 8 Pages